blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1205218

EP1205218 - Topical antipsoriaticum comprising urea, a corticoid and a desinfectant [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  04.02.2005
Database last updated on 02.09.2024
Most recent event   Tooltip14.12.2007Lapse of the patent in a contracting state
New state(s): PT		published on 16.01.2008  [2008/03]
Applicant(s)For all designated states
Benkert, Eugen Georg, Dr.med.dent.
Frankenstrasse 8
76532 Baden-Baden / DE
[2002/20]
Inventor(s)01 / see applicant
...
 [2002/20]
Representative(s)Hellmayr, Wolfgang
Gallenbacher Strasse 13
76534 Baden-Baden / DE
[N/P]
Former [2002/20]Hellmayr, Wolfgang, Dr. rer. nat.
Gallenbacher Strasse 13
76534 Baden-Baden / DE
Application number, filing date00124790.714.11.2000
[2002/20]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP1205218
Date:15.05.2002
Language:DE
[2002/20]
Type: B1 Patent specification 
No.:EP1205218
Date:31.03.2004
Language:DE
[2004/14]
Search report(s)(Supplementary) European search report - dispatched on:EP15.06.2001
ClassificationIPC:A61P17/06, A61K45/06, A61K31/57, A61K31/17, A61K31/473, A61K31/47
[2003/25]
CPC:
A61K31/47 (EP); A61K31/155 (EP); A61K31/17 (EP);
A61K31/565 (EP); A61K31/57 (EP); A61K31/575 (EP);
A61K45/06 (EP); A61P17/06 (EP) (-)
C-Set:
A61K31/155, A61K2300/00 (EP);
A61K31/47, A61K2300/00 (EP);
A61K31/57, A61K2300/00 (EP);
A61K31/57, A61K31/17, A61K31/085 (EP);
A61K31/57, A61K31/17, A61K31/12 (EP);
A61K31/57, A61K31/47, A61K31/17 (EP)
(-)
Former IPC [2002/20]A61P17/06, A61K45/06, A61K31/57
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/06]
Former [2002/20]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE,  TR 
TitleGerman:Topical-Antipsoriaticum mit Harnstoff, einem Corticoid und einem Desinfektionsmittel[2002/20]
English:Topical antipsoriaticum comprising urea, a corticoid and a desinfectant[2002/20]
French:Antipsoriatrique topical comprenant de l'urée, un corticoide et un désinfectant[2002/20]
Examination procedure14.09.2001Amendment by applicant (claims and/or description)
21.06.2002Examination requested  [2002/35]
22.08.2002Despatch of a communication from the examining division (Time limit: M04)
06.12.2002Reply to a communication from the examining division
23.05.2003Communication of intention to grant the patent
28.07.2003Fee for grant paid
28.07.2003Fee for publishing/printing paid
08.10.2003Despatch of a communication from the examining division (Time limit: M02)
06.11.2003Reply to a communication from the examining division
Opposition(s)04.01.2005No opposition filed within time limit [2005/12]
Fees paidRenewal fee
29.11.2002Renewal fee patent year 03
09.12.2003Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
30.11.200304   M06   Fee paid on   02.01.2004
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY31.03.2004
FI31.03.2004
GB31.03.2004
IE31.03.2004
IT31.03.2004
NL31.03.2004
TR31.03.2004
DK30.06.2004
GR30.06.2004
SE30.06.2004
ES12.07.2004
PT31.08.2004
LU14.11.2004
BE30.11.2004
MC30.11.2004
[2008/03]
Former [2007/35]CY31.03.2004
FI31.03.2004
GB31.03.2004
IE31.03.2004
IT31.03.2004
NL31.03.2004
TR31.03.2004
DK30.06.2004
GR30.06.2004
SE30.06.2004
ES12.07.2004
LU14.11.2004
BE30.11.2004
MC30.11.2004
Former [2007/08]CY31.03.2004
FI31.03.2004
GB31.03.2004
IE31.03.2004
NL31.03.2004
TR31.03.2004
DK30.06.2004
GR30.06.2004
SE30.06.2004
ES12.07.2004
LU14.11.2004
BE30.11.2004
MC30.11.2004
Former [2006/51]FI31.03.2004
GB31.03.2004
IE31.03.2004
NL31.03.2004
TR31.03.2004
DK30.06.2004
GR30.06.2004
SE30.06.2004
ES12.07.2004
BE30.11.2004
MC30.11.2004
Former [2006/13]FI31.03.2004
GB31.03.2004
IE31.03.2004
NL31.03.2004
DK30.06.2004
GR30.06.2004
SE30.06.2004
ES12.07.2004
BE30.11.2004
MC30.11.2004
Former [2005/51]FI31.03.2004
GB31.03.2004
IE31.03.2004
DK30.06.2004
GR30.06.2004
SE30.06.2004
ES12.07.2004
BE30.11.2004
MC30.11.2004
Former [2005/48]FI31.03.2004
GB31.03.2004
IE31.03.2004
DK30.06.2004
GR30.06.2004
SE30.06.2004
ES12.07.2004
MC30.11.2004
Former [2005/19]FI31.03.2004
GB31.03.2004
IE31.03.2004
DK30.06.2004
GR30.06.2004
SE30.06.2004
ES12.07.2004
Former [2005/18]FI31.03.2004
GB31.03.2004
DK30.06.2004
GR30.06.2004
SE30.06.2004
ES12.07.2004
Former [2005/02]FI31.03.2004
GB31.03.2004
GR30.06.2004
SE30.06.2004
ES12.07.2004
Former [2005/01]FI31.03.2004
GB31.03.2004
GR30.06.2004
SE30.06.2004
Former [2004/41]FI31.03.2004
GR30.06.2004
SE30.06.2004
Former [2004/40]FI31.03.2004
SE30.06.2004
Documents cited:Search[X]DE1817288  (CIBA GEIGY) [X] 1-3,5-7 * pages 2-3; examples 3-5; claims 1,7,8,10,11,13-15,17-21 *;
 [A]EP0006724  (PHARES PHARM RES NV [NL]) [A] 1-7 * page 10; examples 4-7 * * page 1, lines 12-20 *;
 [X]US4367224  (VAN SCOTT EUGENE J [US], et al) [X] 1-5,7 * column 3, lines 20-24; claims 1,3,6 * * column 2, lines 50-52; claim 13 *;
 [X]GB2116425  (ROEHM PHARMA GMBH) [X] 1-3,5,6 * page 2, lines 3-20; example 7; claims 1-3,12 *;
 [X]US4512978  (INWOOD LOUIS R [US]) [X] 1-3,5-7 * column 2, lines 49-58; example 10; claims 1,3,15,17 * * column 3, lines 53-57 * * column 4, lines 7-11 * * column 4, lines 41,42 *;
 [X]EP0224837  (ROEHM PHARMA GMBH [DE]) [X] 1-4 * page 2, lines 49-52; claims 8,9 * * page 3, lines 32-49; claim 10 *;
 [A]EP0717994  (LUJAMBIO GALDEANO IGNACIO ANTO [ES]) [A] 1-3,7 * the whole document *;
 [X]WO0057845  (JOHNSON & JOHNSON CONSUMER [US]) [X] 1-4,7 * page 10; claims 1,22,25,26 * * page 8, lines 1-12; example 1 * * page 12, lines 30,31 *;
 [A]  - WOLF B ET AL, "UNTERSUCHUNGEN ZUR KOMPATIBILITAET VON WIRKSTOFFHALTIGEN DERMATIKA MIT ZUSAETZLICH EINGEARBEITETEN WIRKSTOFFEN", PHARMAZIE,DD,VEB VERLAG VOLK UND GESUNDHEIT. BERLIN, (1996), vol. 51, no. 12, ISSN 0031-7144, pages 966 - 970, XP000651797 [A] 1-6 * page 969, column L; table 1 *
 [A]  - BUDAVARI ET AL, The Merck Index 12th Edn., WHITEHOUSE STATION NJ, MERCK & CO. INC., (1996), XP002167135 [A] 1,4,7 * pages 115-116 *
 [A]  - BRIEDE, R. H., "Application of carbomer-water gel 1%", PHARM. WEEKBL. (1983), 118(9), 170-4, XP001001186 [A] 1-6 * page 172, column R *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.